Literature DB >> 17473060

Effects of blood glucose rate of changes on perceived mood and cognitive symptoms in insulin-treated type 2 diabetes.

Daniel J Cox1, Anthony McCall, Boris Kovatchev, Samiha Sarwat, Liza L Ilag, Meng H Tan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17473060     DOI： 10.2337/dc06-2480

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  17 in total

Review 1.  Measures of glycemic variability and links with psychological functioning.

Authors:  Joseph R Rausch
Journal:  Curr Diab Rep       Date:  2010-12       Impact factor: 4.810

Review 2.  Glycemic Variability: How to Measure and Its Clinical Implication for Type 2 Diabetes.

Authors:  Guillermo E Umpierrez; Boris P Kovatchev
Journal:  Am J Med Sci       Date:  2018-10-02       Impact factor: 2.378

Review 3.  Metrics for glycaemic control - from HbA1c to continuous glucose monitoring.

Authors:  Boris P Kovatchev
Journal:  Nat Rev Endocrinol       Date:  2017-03-17       Impact factor: 43.330

Review 4.  Systematic review: comparative effectiveness and safety of premixed insulin analogues in type 2 diabetes.

Authors:  Rehan Qayyum; Shari Bolen; Nisa Maruthur; Leonard Feldman; Lisa M Wilson; Spyridon S Marinopoulos; Padmini Ranasinghe; Muhammed Amer; Eric B Bass
Journal:  Ann Intern Med       Date:  2008-09-15       Impact factor: 25.391

5.  The median is not the only message: a clinician's perspective on mathematical analysis of glycemic variability and modeling in diabetes mellitus.

Authors:  Anthony L McCall; Boris P Kovatchev
Journal:  J Diabetes Sci Technol       Date:  2009-01

6.  Diabetes and driving.

Authors:  Daniel Lorber; John Anderson; Shereen Arent; Daniel J; Brian M Frier; Michael A Greene; John W Griffin; Gary Gross; Katie Hathaway; Irl Hirsch; Daniel B Kohrman; David G Marrero; Thomas J Songer; Alan L Yatvin
Journal:  Diabetes Care       Date:  2012-01       Impact factor: 19.112

7.  Dipeptidyl peptidase-4 inhibitor improves glycemic variability in multiple daily insulin-treated type 2 diabetes: a prospective randomized-controlled trial.

Authors:  Fukumi Yoshikawa; Tomoko Nagashima; Hiroshi Uchino; Shuki Usui; Masahiko Miyagi; Yasuyo Ando; Takahisa Hirose
Journal:  Diabetol Int       Date:  2021-06-05

Review 8.  Minimizing Glycemic Fluctuations in Patients with Type 2 Diabetes: Approaches and Importance.

Authors:  Paresh Dandona
Journal:  Diabetes Technol Ther       Date:  2017-08-03       Impact factor: 6.118

9.  Diabetes and driving.

Authors:  Daniel Lorber; John Anderson; Shereen Arent; Daniel J Cox; Brian M Frier; Michael A Greene; John W Griffin; Gary Gross; Katie Hathaway; Daniel B Kohrman; David G Marrero; Thomas J Songer; Alan L Yatvin
Journal:  Diabetes Care       Date:  2013-01       Impact factor: 19.112

10.  Glycemic Variability and Its Impact on Quality of Life in Adults With Type 1 Diabetes.

Authors:  Monika Reddy; Ian F Godsland; Katharine D Barnard; Pau Herrero; Pantelis Georgiou; Hazel Thomson; Desmond G Johnston; Nick S Oliver
Journal:  J Diabetes Sci Technol       Date:  2015-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.